All News Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Market Closed - Nyse Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
1.21 ^USD	+0.83%		+5.22%	-32.02%

Mar. 14	Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
Mar. 14	Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	Mar. 15	AQ
Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024	Mar. 14
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	Mar. 08	AQ
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	Feb. 26	AQ
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	Nov. 07	AQ
Transcript : Protalix BioTherapeutics, Inc., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Protalix: Q3 Earnings Snapshot	Nov. 06	AQ
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	Nov. 06	MT
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	23-10-31	AQ
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating	23-10-31	MT
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23-10-23	PU
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel	23-10-10	AQ
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors	23-09-13	AQ
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023	23-09-11	CI
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-07	AQ
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results	23-08-08	AQ
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)	23-08-07	PU
Transcript : Protalix BioTherapeutics, Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

All News

Filters